VOVA IDA THERAPEUTICS INC
Biotech · Private
Small-molecule drug targeting intracellular Aβ42 oligomer signaling in Alzheimer's disease
- Grants
- $867K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 0 granted · 9 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201920202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Targeting neurotoxic alpha-synuclein aggregates for Parkinson's disease therapy. | $376,286 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a lead candidate for the treatment of Alzheimer's disease | $390,685 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a lead candidate for the treatment of Alzheimer's disease | $100,250 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2697 | SUDHIN BIOPHARMA COMPANY | — | — |
| 2698 | MC1R VENTURES LLC | — | — |
| 2699 | SpinCeutica, Inc. | — | — |
| 2700 | VOVA IDA THERAPEUTICS INC | — | — |
| 2701 | ZVELT THERAPEUTICS INC. | — | — |
| 2702 | DUB THERAPEUTICS INC. | — | — |
| 2703 | EDI THERAPEUTICS LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Nicotinamide Dinucleotide (nad) Detection And Quantificationapplication
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Compounds And Use Thereof For Treatment Of Neurodegenerative, Degenerative And Metabolic Disordersapplication
- Nicotinamide Dinucleotide (nad) Detection And Quantificationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.